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INTRODUCTION
The monoclonal gammopathies (MG) are monoclonal neo-
plasms related to each other by virtue of their development
from common progenitors in the B lymphocyte lineage. The
clinical manifestations of MG relate to the expansion of the
neoplastic cells, to the secretion of cell products, and to some
extent to the host’s response to the tumor (1, 2).
There have been numerous reports of multiple myeloma and
related disorders with systemic amyloidosis associated with
heart involvement (3-7). However, cardiac dysfunction asso-
ciated with MG has scarcely been reported. We report a case
of cardiac dysfunction associated with MG in which the diag-
nosis was made by echocardiography and biopsy.
CASE REPORT
A 59-yr-old man visited outpatient clinic for evaluation of
progressive dyspnea on exertion and chest discomfort for 4
months. He had no remarkable medical and family history. 
On the physical examination, his height was 170 cm, weight
77 kg, the blood pressure 104/66 mmHg, the heart rate 76/
min, the respiratory rate 20/min, and the body temperature
36℃. He had clear mentality, chronic ill-looking appearance
and clear sclerae. Jugular venous distension was noted, but no
cervical and axial lymphadenopathy was observed. The heart
sounds were regular without murmur, but presystolic gallop
(S4) was checked. The breath sounds were clear without rales
or wheezing. Abdominal examination revealed normal bowel
sounds without any palpable mass. There was no definite pit-
ting edema. Otherwise the physical findings were unremark-
able.
The blood cell counts were as follows: the hemoglobin 13.0
gm/dL, the white blood cell count 6,700/μ L, and the platelet
count 198,000/μ L. According to the serological biochemical
assay, fasting blood sugar was 107 mg/dL, Na+ 142 mEq/L,
K+ 4.0 mEq/L, Ca2+ 9.6 mg/dL, P- 3.7 mg/dL, blood urea
nitrogen 12 mg/dL, creatinine 0.9 mg/dL, total protein 7.0
g/dL, albumin 4.3 g/dL, aspartate transaminase 20 IU/L, ala-
nine transaminase 22 IU/L, alkaline phosphatase 188 IU/L,
lactate dehydrogenase 285 IU/L, and beta-2 microglobulin
1.7 mg/L (normal; 0.8-2.2). Urinalysis showed trace amount
of proteinuria, and the urine Bence-Jones protein was suspect-
ed. Serum protein electrophoresis study was normal. On the
immunochemistry findings, IgG was 1,052 mg/dL (normal;
700-1,600), IgA 105 mg/dL (normal; 70-400), IgM 49 mg/
dL (normal; 40-230), and IgE was elevated as 385 IU/mL
(normal; 10-180). In serum and urine immunoelectrophore-
sis study, lambda type MG was shown (Fig. 1).
The chest radiography film showed a slightly enlarged car-
diac silhouette and there was no pulmonary congestion. There
was no bony lesion on plain skull radiography. Electrocardio-
graphy (ECG) showed regular sinus rhythm, intermittent atri-
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A Case of Cardiac Dysfunction Associated with Monoclonal
Gammopathy of Undetermined Significance
The monoclonal gammopathies (MG) are monoclonal neoplasms related to each
other by virtue of their development from common progenitors in the B lymphocyte
lineage. Cardiac dysfunction in patients with MG is not well established. We expe-
rienced a case of cardiac dysfunction associated with MG identified by echocardio-
graphy and biopsy. Fifty nine year-old man was admitted because of dyspnea for
several months. Echocardiography revealed diastolic dysfunction showing restric-
tive physiology with elevated left ventricular filling pressure. Bone marrow (BM) stud-
ies and immunoelectrophoresis were compatible with monoclonal gammopathy of
undetermined significance. Endomyocardial, BM, and enteral biopsies for ruling out
for amyloidosis (Congo-red stain) were negative. This is the case of non-amyloidot-
ic light chain deposition cardiomyopathy.
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al premature beats, poor R wave progression, and Q wave in
precordial leads (Fig. 2).
The echocardiography revealed dilated both atria, concen-
tric left ventricular (LV) hypertrophy (end-diastolic interventric-
ular septum thickness=13 mm and end-diastolic posterior wall
thickness=13 mm, respectively). Both LV dimension and LV
ejection fraction were within normal limits. On the Doppler
study, ratio of early mitral inflow (E) to late filling velocity
(A) (E/A) was 3.0, deceleration time was 135 msec. Tissue
Doppler showed 4.03 cm/sec of early diastolic mitral annular
velocity (E’) with E/E’ ratio of 21.6, suggesting restrictive phys-
iology of diastolic dysfunction with elevated LV filling pres-
sure (Fig. 3). There was scanty amount of pericardial effusion
without definite evidence of constriction.
Bone marrow (BM) aspirate smears showed normocellular
marrow particle, and estimated M:E ratio was 1.71:1. The gr-
anulocyte series were normal in number and showed good mat-
uration sequences. Plasma cells were increased and counted up
to 6.8% of absolute neutrophil count compatible with mon-
oclonal gammopathy of undetermined significance (MGUS)
(Fig. 4). There were no amorphous eosinophilic amyloid mate-
rial in both H&E and Congo-red staining for ruling out amy-
loidosis for endomyocardial (Fig. 5A), BM, and enteral biop-
sies. However, immunostaining for lambda light chain in myo-
cardium showed positive result (Fig. 5B).
The presentation was clinically consistent with non-amy-
loidotic light chain deposition cardiomyopathy (8). He was
managed conservatively with low-dose vasodilators and diuret-
ics, and his symptom mildly resolved. After 9 months follow
up, he readmitted for aggravated heart failure, and died due to
intractable heart failure and ventricular arrhythmia in the end.
DISCUSSION
In this case, we suspected restrictive cardiomyopathy from
ECG and echocardiographic findings. Since cardiac amyloi-
dosis should be considered in any elderly patient with restric-
tive cardiomyopathy of unknown cause (3, 9, 10), we took
multiple site biopsies including endomyocardium and rectum,
which showed no birefringence with Congo-red stain when
viewed under polarized light. In a patient who presents with
Fig. 1. In serum (left) and urine (right) immunoelectrophoresis study,
lambda type monoclonal gammopathy was shown.
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Fig. 2. Electrocardiogram demonstrated regular sinus rhythm with
premature atrial beat, left axis deviation, and poor R progression
on precordial leads.
Fig. 3. Echocardiography demonstrated increased thickness of
the left ventricle (LV) wall and both atrial enlargement and normal
systolic function with normal wall motion. Mitral inflow and mitral
anular Doppler tissue velocities showed grade 3 diastolic dysfunc-
tion and high E/E’, suggesting markedly elevated LV filling pressure.
Fig. 4. In bone marrow biopsy, plasma cells were increased and
counted up to 6.8% of absolute neutrophil count. (H&E stain, ×200).
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a monoclonal gammopathy, additional testing is warranted,
including examination of aspirated BM and a skeletal survey,
to rule out multiple myeloma and to confirm the diagnosis
of MGUS (2). So, we performed BM biopsy and confirmed
MGUS, and concluded this case as a non-amyloidotic light
chain deposition cardiomyopathy (8, 11) with restrictive phys-
iology of diastolic dysfunction associated with MGUS. Light
chain deposition disease, which was first reported by Randall
et al. (12), is a systemic disorder characterized by the deposi-
tion of monoclonal immunoglobulin light chains in various
organs. The main cardiac manifestation is congestive heart
failure as a form of restrictive cardiomyopathy (13, 14). How-
ever, in rare cases, paraproteinemia can deposite as a non-fib-
rillary infiltrate that does not show typical amyoloidosis but
resembles its clinical features as in our patient. And non-amy-
loidotic light chain deposition cardiomyopathy should be con-
sidered and endomyocardial biopsy may be needed for the dif-
ferential diagnosis of restrictive cardiomyopathy (8, 9).
In conclusion, here we present a case showing cardiac dys-
function associated with MGUS in which the diagnosis was
made by echocardiography and biopsy. We should consider
cardiac involvement associated with systemic infiltrative dis-
ease, especially MG, in the differential diagnosis for patients
with cardiac dysfunction of unknown cause.
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Fig. 5. (A) Right ventricular endomyocardial biopsy with Congo-red stain did not show apple-green birefringence in polarized light (×200).
(B) Same specimen of immunostaining for lambda light chain showed positive for perivascular deposition of immunoglobulins (brown color,
×400).
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